High Grade Astrocytic Tumor
1 clinical trials · Condition
◉ Watch High Grade Astrocytic Tumor
| Record | Firm | Date |
|---|---|---|
| Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma (NCT05465954) | Mayo Clinic | 2023-01-24 |
Track High Grade Astrocytic Tumor automatically
Every clearance here is in the API, with alerts when new ones post.